Literature DB >> 15352640

Management of dyspnea.

Jay R Thomas1, Charles F von Gunten.   

Abstract

Patients with cancer frequently report dyspnea, the uncomfortable awareness of breathing. Lung involvement with cancer does not predict its occurrence. Patients describe it as one of the most frightening and distressing symptoms, and patient self-report is the only reliable measure. Measurements of respiratory rate, oxygen saturation, and arterial blood gases do not measure dyspnea. Opioids in modest doses have been demonstrated to give effective relief of dyspnea, whether or not identifiable reversible causes exist. Medical management of dyspnea can be directed at the underlying cause when the potential benefits outweigh the burdens of such treatment. In rare cases where symptomatic treatment is unable to control dyspnea to the patient's satisfaction, sedation is an effective, ethical option.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15352640     DOI: 10.1007/978-1-59745-291-5_1

Source DB:  PubMed          Journal:  J Support Oncol        ISSN: 1544-6794


  8 in total

Review 1.  The management of dyspnea in cancer patients: a systematic review.

Authors:  Raymond Viola; Cathy Kiteley; Nancy S Lloyd; Jean A Mackay; Julie Wilson; Rebecca K S Wong
Journal:  Support Care Cancer       Date:  2008-01-24       Impact factor: 3.603

Review 2.  Symptom management in metastatic breast cancer.

Authors:  William Irvin; Hyman B Muss; Deborah K Mayer
Journal:  Oncologist       Date:  2011-08-31

3.  Dyspnea in palliative care: expanding the role of corticosteroids.

Authors:  Richard J Lin; Ronald D Adelman; Sonal S Mehta
Journal:  J Palliat Med       Date:  2012-03-02       Impact factor: 2.947

Review 4.  Pathophysiology and diagnosis of dyspnea in patients with advanced cancer.

Authors:  Gudrun Pohl; Jan Gaertner
Journal:  Wien Med Wochenschr       Date:  2009-12

5.  Evaluation of diagnostic and treatment approaches towards acute dyspnea in a palliative care setting among medical students at the University of Vienna.

Authors:  Gudrun Pohl; Christine Marosi; Karin Dieckmann; Gregor Goldner; Katarzyna Elandt; Marco Hassler; Michael Schemper; Kathrin Strasser-Weippl; Friedemann Nauck; Jan Gaertner; Herbert Watzke
Journal:  Wien Med Wochenschr       Date:  2012-01

6.  Use of palliative sedation for intractable symptoms in the palliative care unit of a comprehensive cancer center.

Authors:  Ahmed Elsayem; Eardie Curry Iii; Jeanette Boohene; Mark F Munsell; Bianca Calderon; Frank Hung; Eduardo Bruera
Journal:  Support Care Cancer       Date:  2008-05-07       Impact factor: 3.603

7.  Role of intranasal fentanyl in breakthrough pain management in cancer patients.

Authors:  Wojciech Leppert
Journal:  Cancer Manag Res       Date:  2010-09-30       Impact factor: 3.989

Review 8.  Management of Breathlessness in Palliative Care: Inhalers and Dyspnea-A Literature Review.

Authors:  Helen Senderovich; Akash Yendamuri
Journal:  Rambam Maimonides Med J       Date:  2019-01-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.